RIGEL PHARMACEUTICALS, INC. (RIGL) Operating margin 2016–2025
RIGEL PHARMACEUTICALS, INC. (RIGL) operating margin by fiscal year — reported operating income divided by reported revenue.
42.6%FY2025 · since FY2016: -342.2% → 42.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 42.6% | +29.1 pp |
| FY2024 | 13.5% | +31.0 pp |
| FY2023 | -17.5% | +28.7 pp |
| FY2022 | -46.2% | -37.8 pp |
| FY2021 | -8.4% | +18.3 pp |
| FY2020 | -26.7% | +89.9 pp |
| FY2019 | -116.5% | +46.8 pp |
| FY2018 | -163.3% | +1612.3 pp |
| FY2017 | -1775.6% | -1433.4 pp |
| FY2016 | -342.2% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More RIGL financial trends
RIGL RevenueRIGL Net incomeRIGL Net marginRIGL Gross profitRIGL Gross marginRIGL Operating incomeRIGL Operating cash flowRIGL Free cash flowRIGL Capital expendituresRIGL Return on equityRIGL Stock buybacksRIGL Dividends paidRIGL Total assetsRIGL Total liabilitiesRIGL Shareholders’ equityRIGL overview →